Vendor, Atlanta, GA
Lymphatech, Inc.
UEI W7JWEZ412CR3, CAGE 78PR8
1 award and $4,100,000 obligated between September 12, 2024 and November 4, 2025, 100% under full and open competition, against 2.0 offers on average where reported. 7 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $4,100,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Hear when Lymphatech, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Lymphatech, Inc.'s contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) to National Institutes of Health, by dollars.
| Leidos Biomedical Research Inc.Frederick, MD | $2,186,453,292 |
| Westat, Inc.Rockville, MD | $762,955,645 |
| Technical Resources International, Inc.Bethesda, MD | $196,391,189 |
| Duke UniversityDurham, NC | $158,758,507 |
| MriglobalKansas City, MO | $117,921,746 |
| The Johns Hopkins UniversityBaltimore, MD | $100,932,043 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91024C00018Definitive Contract, September 12, 2024, Full and Open Competition After Exclusion of Sources, 2 offersSolicitation | NIH NCINational Institutes of Health | ALL-IN-ONE Pressure, Flow Control, and Imaging for Culturing and Monitoring Lymphatic Microphysiologic SystemNAICS 541715, PSC AN13 | $4,100,000 |
- Places of performance
- Georgia
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 5 across 1 awards